How To Sell To The C Suite

Jun 20, 2023

How To Sell To The C Suite

Cs (CEOs, COOs, CIOs, etc.) speak their own language. They are focused on strategy, team-building, market share, growth, margins, competition and capital allocation. Before you meet, do your research on their company and have a point of view about how your offering can impact one or more of these areas in a measurable way.

Keep in mind that emotions, backed up by facts, drive buying decisions. Risk (i.e. fear) and ego are some of the most common and powerful emotions we see. Prepare insights as early as possible to show your C-level buyer how your offering will reduce risk and make them stand-out in the industry. Back them up with hard numbers and you will be on your way to closing more deals.

Why AI in Healthcare Must Start With Strategy—Not Shiny Tools

Why AI in Healthcare Must Start With Strategy—Not Shiny Tools

Early Google engineer and Silicon Valley innovator Murali Vivekanandan, CEO of Ideas2IT, brings a rare blend of tech and healthcare expertise to the Sparxcast Unleashed podcast. In this conversation, he explains why AI’s impact on healthcare depends less on flashy pilots and more on building a strategic foundation—one that balances operational efficiency, clinical safety, and long-term competitiveness.

Vivekanandan shares how providers, payers, and service organizations can move beyond “vendor roadmaps” to own their AI destiny, with practical advice on building data backbones, applying human-in-the-loop safeguards, and proving ROI step by step. He also opens up about scaling a 750-person engineering firm with almost no turnover—by putting employee happiness ahead of everything else.

Redefining Pain Care: Why Access to Opioids Is a Healthcare Imperative

Redefining Pain Care: Why Access to Opioids Is a Healthcare Imperative

OPOS CEO and Founder Justin Kromelow shares an evidence-backed perspective on the opioid crisis—and the patients being left behind. With 25 million Americans relying on long-term opioid therapy to maintain independence and quality of life, Kromelow explains why blanket restrictions have created a second crisis: a collapse in access for those who need it most.

Justin walks through a smarter, safer model for opioid management—one that empowers providers with regulatory support, elevates patient function over pain scores, and restores profitability to practices while dramatically improving outcomes. He also opens up about OPOS’s rapid growth and his mission to rewrite the standard of care.

Listen to the SparxCast Unleashed Podcasts 🎧